Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05013333 · ClinicalTrials.gov registry record · NA

AED 3 Post-Approval Study

A NA study of Cardiac Arrest, Out-Of-Hospital, sponsored by Zoll Medical Corporation.

Active
Registry status
NA
Development phase
38
Enrollment target
2
Study locations

NCT05013333: Active NA study of Cardiac Arrest, Out-Of-Hospital, sponsored by Zoll Medical Corporation.

NCT05013333 is a NA study of Cardiac Arrest, Out-Of-Hospital that is active but no longer recruiting, run by Zoll Medical Corporation. The registered enrollment target is 38 participants, below the 1,618-participant average among 5 other Cardiac Arrest, Out-Of-Hospital trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05013333, a NA study of Cardiac Arrest, Out-Of-Hospital, is active but no longer recruiting, sponsored by Zoll Medical Corporation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
38 participants
Enrollment target
2
Study locations

Study Summary

Demonstrate appropriate CPR sensor placement on pediatric and adult patients and demonstrate delivery of appropriate energy level of shocks to pediatric and adult patients.

Primary Outcome

Rate of appropriate placement of the CPR electrodes and compression sensor

Interventions

  • DEVICE AED 3 with Uni-padz

Study Locations (2)

New York

  • University at Buffalo - Buffalo
  • Colonie EMS - Latham

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2021-03-30
Est. Completion 2029-02-28
Phase NA
Zoll Medical Corporation

24 total trials

What the registry record for NCT05013333 still lists

NCT05013333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,618-participant average among 5 other Cardiac Arrest, Out-Of-Hospital trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Cardiac Arrest, Out-Of-Hospital appearing as the primary indexed condition, and to 1 intervention - of which AED 3 with Uni-padz is the first listed.

NCT05013333 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05013333 about?

NCT05013333 is a clinical study titled "AED 3 Post-Approval Study". Demonstrate appropriate CPR sensor placement on pediatric and adult patients and demonstrate delivery of appropriate energy level of shocks to pediatric and adult patients.

What is the current status of trial NCT05013333?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2021-03-30. Estimated completion is 2029-02-28.

What conditions does trial NCT05013333 study?

This clinical trial studies the following conditions: Cardiac Arrest, Out-Of-Hospital.

What interventions are being tested in trial NCT05013333?

The interventions under investigation include: AED 3 with Uni-padz (DEVICE).

Who is sponsoring clinical trial NCT05013333?

This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05013333 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrest, Out-Of-Hospital

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05013333, the US trial registry maintained by the National Library of Medicine. NCT05013333 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.